Léveillé, N; Elkon, R; Davalos, V; Manoharan, V; Hollingworth, D; Oude Vrielink, J; le Sage, C; ... Agami, R; + view all Léveillé, N; Elkon, R; Davalos, V; Manoharan, V; Hollingworth, D; Oude Vrielink, J; le Sage, C; Melo, CA; Horlings, HM; Wesseling, J; Ule, J; Esteller, M; Ramos, A; Agami, R; - view fewer (2011) Selective inhibition of microRNA accessibility by RBM38 is required for p53 activity. Nature Communications , 2 , Article 513. 10.1038/ncomms1519.

Preview

PDF ncomms1519.pdf Download (2MB)

Abstract

MicroRNAs (miRNAs) interact with 3'-untranslated regions of messenger RNAs to restrict expression of most protein-coding genes during normal development and cancer. RNA-binding proteins (RBPs) can control the biogenesis, stability and activity of miRNAs. Here we identify RBM38 in a genetic screen for RBPs whose expression controls miRNA access to target mRNAs. RBM38 is induced by p53 and its ability to modulate miRNA-mediated repression is required for proper p53 function. In contrast, RBM38 shows lower propensity to block the action of the p53-controlled miR-34a on SIRT1. Target selectivity is determined by the interaction of RBM38 with uridine-rich regions near miRNA target sequences. Furthermore, in large cohorts of human breast cancer, reduced RBM38 expression by promoter hypermethylation correlates with wild-type p53 status. Thus, our results indicate a novel layer of p53 gene regulation, which is required for its tumour suppressive function.

Download activity - last month

Export as CSVJSONXML

Download activity - last 12 months

Export as JSONCSVXML

Downloads by country - last 12 months

Export as XMLCSVJSON

Archive Staff Only

View Item